Bill SponsorBILLSPONSOR
Bill Sponsor
Politicians
Bills
House Bill 4236
115th Congress(2017-2018)
MONITOR Act of 2017
Introduced
Introduced
Introduced in House on Nov 3, 2017
Overview
Text
Introduced in House 
Nov 3, 2017
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Introduced in House(Nov 3, 2017)
Nov 3, 2017
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Jump To
H. R. 4236 (Introduced-in-House)


115th CONGRESS
1st Session
H. R. 4236


To ensure that the prescription drug monitoring program of each State receiving funds through the Account for the State Response to the Opioid Abuse Crisis meets certain minimum requirements, and for other purposes.

IN THE HOUSE OF REPRESENTATIVES

November 3, 2017

Mr. Fitzpatrick (for himself, Ms. Kuster of New Hampshire, Mr. MacArthur, and Mr. Norcross) introduced the following bill; which was referred to the Committee on Energy and Commerce

A BILL

To ensure that the prescription drug monitoring program of each State receiving funds through the Account for the State Response to the Opioid Abuse Crisis meets certain minimum requirements, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Monitoring and Obtaining Needed Information to Track Opioids Responsibly Act of 2017” or the “MONITOR Act of 2017”.

SEC. 2. Minimum requirements for State prescription drug monitoring programs.

Section 1003 of the 21st Century Cures Act (42 U.S.C. 290ee–3 note; relating to the Account for the State Response to the Opioid Abuse Crisis) is amended—

(1) by redesignating subsection (f) as subsection (g); and

(2) by inserting after subsection (e) the following:

“(f) Minimum requirements for State prescription drug monitoring programs.—

“(1) IN GENERAL.—As a condition on receipt of a grant under this section, a State shall—

“(A) certify that the State has in effect a prescription drug monitoring program meeting the requirements of paragraph (2); or

“(B) agree to use a portion of the funds received through the grant to meet (or make progress in meeting) the requirements of paragraph (2).

“(2) REQUIREMENTS.—To meet the requirements of this paragraph, a State’s prescription drug monitoring program must meet each of the following:

“(A) The program complies with the uniform electronic format specified by the Secretary under paragraph (3) for the reporting, sharing, and disclosure of information.

“(B) The program meets the standards of interoperability specified by the Secretary under paragraph (3).

“(C) The State requires dispensers to report to the program each dispensing in the State of a controlled substance listed in schedule II, III, or IV of section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)) no later than 1 business day after the controlled substance is dispensed to the patient.

“(D) The program makes reported information available to practitioners on a timely basis.

“(3) UNIFORM ELECTRONIC FORMAT; INTEROPERABILITY.—

“(A) ESTABLISHMENT.—Not later than one year after the date of enactment of this Act, the Secretary shall specify for prescription drug monitoring programs—

“(i) a uniform electronic format for the reporting, sharing, and disclosure of information; and

“(ii) standards of interoperability.

“(B) ADVISORY GROUP.—In carrying out subparagraph (A), the Secretary shall—

“(i) convene an advisory group of licensed and practicing community pharmacists and other health practitioners who prescribe and dispense; and

“(ii) take the recommendations of such advisory group into consideration.

“(4) DEFINITIONS.—In this subsection:

“(A) The term ‘controlled substance’ has the meaning given to that term in section 102 of the Controlled Substances Act (21 U.S.C. 802).

“(B) The term ‘dispenser’ means a person licensed or otherwise authorized by a State to deliver a prescription drug product to a patient or an agent of the patient.

“(C) The term ‘practitioner’ means a practitioner registered under section 303(f) of the Controlled Substances Act (21 U.S.C. 823(f)) to prescribe, administer, or dispense controlled substances.

“(D) The term ‘State’ means each of the several States and the District of Columbia.”.